INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 5 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,458 | -22.5% | 7,320 | 0.0% | 0.05% | -23.5% |
| Q2 2023 | $298,510 | +9.4% | 7,320 | 0.0% | 0.07% | -1.4% |
| Q1 2023 | $272,816 | +13.0% | 7,320 | +5.8% | 0.07% | -12.7% |
| Q4 2022 | $241,439 | -37.6% | 6,920 | 0.0% | 0.08% | -39.2% |
| Q3 2022 | $387,000 | +8.1% | 6,920 | 0.0% | 0.13% | +12.1% |
| Q2 2022 | $358,000 | -12.9% | 6,920 | +22.3% | 0.12% | -4.1% |
| Q1 2022 | $411,000 | -38.6% | 5,660 | 0.0% | 0.12% | -37.3% |
| Q4 2021 | $669,000 | -11.9% | 5,660 | 0.0% | 0.19% | -22.2% |
| Q3 2021 | $759,000 | -17.1% | 5,660 | 0.0% | 0.25% | -18.7% |
| Q2 2021 | $916,000 | +101.8% | 5,660 | 0.0% | 0.30% | +69.4% |
| Q1 2021 | $454,000 | +48.9% | 5,660 | +1.1% | 0.18% | +20.8% |
| Q4 2020 | $305,000 | – | 5,601 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
| Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
| MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
| Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
| ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
| Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
| Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
| Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |